CoC Payment definition

CoC Payment is defined in Section 6.2(c)(i).
View Source
CoC Payment means (i) any Change in Control Benefits provided to you under Part Two of this Agreement which is deemed to constitute a parachute payment within the meaning of Code Section 280G(b)(2) and the Treasury Regulations issued thereunder, (ii) any Option COC Payment attributable to your Acquisition-Accelerated Options, (iii) any RSU COC Payment attributable to your Acquisition-Accelerated RSUs and (iv) any Stock Appreciation Right COC Payment attributable to your Acquisition-Accelerated Stock Appreciation Rights.
View Source
CoC Payment means any payment made by (or on behalf of) a Fund or Fund Subsidiary to a Joint Venture Counterparty, Contract Counterparty or Lender Counterparty for the purpose of obtaining such CoC Counterparty’s consent or waiver in connection with a Change of Control Event;
View Source

Examples of CoC Payment in a sentence

  • The Seller shall remit the CoC Payment to the Buyer on the CoC Payment due date, and such CoC Payment shall include the foregoing amount of such final Royalty Payment.

  • If the Seller elects to exercise the Buy-Back Option, or if the Buyer Representative (if more than one Buyer, on behalf of all Buyers) exercises the Buy-Back Requirement by delivering notice to the Seller within [***] after receiving such notice from the Seller, the Seller shall or shall cause to, promptly but no later than [***] following the consummation of such Change of Control, pay the CoC Payment to the Buyer.

  • The Seller’s obligation to pay the CoC Payment following the Seller’s exercise of the Buy-Back Option or the Buyer Representative’s exercise of the Buy-Back Requirement shall be contingent upon the consummation of such Change of Control; if such Change of Control is not consummated, the exercise of such Buy-Back Option or such Buy-Back Requirement shall be void.


More Definitions of CoC Payment

CoC Payment is defined in Section 6.2(c)(i). “Code” means the Internal Revenue Code of 1986, as amended. “Combination Product” means: (a) a single pharmaceutical formulation (whether co-formulated or administered together via the same administration route) containing as its active ingredients both the Product and one or more other therapeutically or prophylactically active pharmaceutical or biologic ingredients (each an “Other Component”), or (b) a combination therapy comprised of the Product and one or more Other Component(s), whether priced and sold in a single package containing such multiple products, packaged separately but sold together for a single price, or sold under separate price points but labeled for use together, in each case, including all dosage forms, formulations, presentations, and package configurations. Drug delivery vehicles, adjuvants and excipients will not be deemed to be “active ingredients”, except in the case where such delivery vehicle, adjuvant or excipient is recognized by the FDA as an active ingredient in accordance with 21 C.F.R. 210.3(b)(7). All references to Products in this Agreement shall be deemed to include Combination Products. “Commercial Updates” means a summary of material updates with respect to the Seller’s
View Source